Takeda’s Shire offer straps rocket to sterling M&A funding

Japanese pharmaceutical company Takeda has bumped up its debt and equity offer for Shire to £46bn, leading to potentially the largest sterling M&A financing of the year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: